ANZ CFO defects to Transurban (ASX:TCL)

22Dec

ANZ CFO defects to Transurban (ASX:TCL)

 

Transurban Group (ASX:TCL) has appointed Michelle Jablko as its new chief financial officer.

She will replace Adam Watson following his resignation in August.

Michelle is currently CFO of the ANZ Bank (ASX:ANZ).

Prior to that she had a carer in investment banking with UBS and Greenhill Australia, and as a lawyer with Allens Linklaters.

Shares in Transurban Group (ASX:TCL) are trading 0.07 per cent lower at $13.99.
 
Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

11Feb

Cochlear (ASX:COH) reduces earnings guidance for FY20

11 Feb 2020 - Medical device company Cochlear (ASX:COH) is reducing the guidance outlook for FY20 from $290-300 million to $270-290 million.

Read More
26Nov

Shannon Coates resigns from board of Flinders Mines (ASX:FMS)

26 Nov 2019 - Iron ore miner, Flinders Mines (ASX:FMS) has announced the resignation of Ms Shannon Coates as a non-executive director.

Read More
19Feb

OceanaGold (ASX:OGC) reports a loss of US$150.4 million

19 Feb 2021 - OceanaGold (ASX:OGC) has a reported a loss of US$150.4 million compared to a $14.5 million profit a year ago.

Read More
17Mar

Corporate Travel Management’s (ASX:CTD) Jamie Pherous disposes 1.5 million shares

17 Mar 2021 - Corporate Travel Management (ASX:CTD) advises that Jamie Pherous has disposed of 1.5 million of their shares.

Read More
04Dec

Unibail-Rodamco-Westfield (ASX:URW) 544.9M bond buy back

04 Dec 2020 - Global property giant Unibail-Rodamco-Westfield (ASX:URW) will repurchase 544.9 million Euros worth of bonds, following the tender offer it announced on 25 November 2020.

Read More
22Mar

Telstra (ASX:TLS) plans biggest restructuring since 1997

22 Mar 2021 - Telco giant Telstra (ASX:TLS) is planning the most comprehensive restructuring program since the company’s privatisation in 1997.

Read More
18Aug

Westpac (ASX:WBC) declare no first-half dividend

18 Aug 2020 - Westpac (ASX:WBC) report unaudited statutory net profit for 3Q20 was $1.12 billion.

Read More
01Jul

Telix (ASX:TLX) granted FDA Break Through status for cancer treatment

01 Jul 2020 - Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy (BT) designation for Telix’s renal cancer imaging product.

Read More
10Dec

Starpharma’s (ASX:SPL) cancer drug progresses to stage 2 trials

10 Dec 2019 - Starpharma's (ASX:SPL) prostate cancer drug DEP cabazitaxel has successfully completed its phase one trials.

Read More
18Feb

Lifestyle Communities (ASX:LIC) first half results driven by 109 new home settlements

18 Feb 2020 - Lifestyle Communities (ASX:LIC) achieved a net profit after tax attributable to shareholders of $15.1 million for the first half of the 2020 financial year, compared to $21.9 million in the same period last year.

Read More